EVALUATION OF HEMATOLOGICAL MARKERS FOR DIAGNOSTIC SIGNIFICANCE IN HELICOBACTER PYLORI INFECTION
DOI:
https://doi.org/10.54112/bcsrj.v2024i1.1333Keywords:
H. pylori , Hematological parameters , Hemoglobin (HGB) , Red blood cell count (RBC) , Mean corpuscular volume (MCV) , Anemia , PlateletsAbstract
Hematological parameters provide valuable insights into various health conditions. This study aimed to evaluate and compare haematological parameters between patients and healthy controls, assessing conditions related to specific haematological markers. Objective: To identify significant differences in haematological parameters, including haemoglobin (HGB), red blood cell count (RBC), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), and red cell distribution width (RDW), between patients and controls. Methods: A comparative cross-sectional study was conducted, including 60 patients and 60 healthy controls. Key haematological parameters were measured and statistically analyzed to evaluate differences between the groups. Additionally, the distribution of conditions such as anaemia, low MCV, and other haematological abnormalities was assessed. Results: Significant differences were observed in several parameters. Patients exhibited lower mean HGB (12.2 ± 1.3 g/dL vs. 14.32 ± 1.46 g/dL, p=0.01), MCV (84.1 ± 2.11 fl vs. 89.16 ± 3.53 fl, p=0.04), MCH (24.6 ± 4.16 pg vs. 28.13 ± 0.87 pg, p=0.001), and MCHC (30.2 ± 2.10 g/dL vs. 31.58 ± 0.24 g/dL, p=0.01) compared to controls. RBC counts were higher in patients (4.42 ± 0.32 × 10^6/µL vs. 3.87 ± 1.53 × 10^6/µL, p=0.02), while RDW showed no significant difference (13.7 ± 1.032% vs. 12.4 ± 1.22%). Regarding conditions among patients: 13% exhibited low HGB, while 9% had normal HGB levels. RBC levels were normal in 92% of patients, with 5% showing low values. HCT levels were predominantly normal (94%), with 12% showing low values. MCV was normal in 87%, with 13% showing low levels. MCH was normal in 85%, with 2% showing low levels. MCHC was normal in 96%, with 1% showing high levels. RDW was normal in 98%, with only 1% showing low levels. Conclusion: The study highlights significant haematological alterations in patients, including lower HGB, MCV, MCH, and MCHC, with normal RBC and HCT levels in most cases. These findings suggest a trend toward anaemia and related conditions in the patient population. Further research is necessary to explore the clinical implications of these alterations.
Downloads
References
Crowe SE. Helicobacter pylori infection. New England Journal of Medicine. 2019;380(12):1158-65.
Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance—from biology to clinical implications. Nature Reviews Gastroenterology & Hepatology. 2021;18(9):613-29.
FitzGerald R, Smith SM. An overview of Helicobacter pylori infection. Helicobacter pylori. 2021:1-14.
Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori infection: clinical features, treatment, and nutritional aspects. Diseases. 2021;9(4):66.
Ren S, Cai P, Liu Y, Wang T, Zhang Y, Li Q, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta‐analysis. Journal of gastroenterology and hepatology. 2022;37(3):464-70.
Godbole G, Mégraud F, Bessède E. Diagnosis of Helicobacter pylori infection. Helicobacter. 2020;25:e12735.
Shimamoto T, Yamamichi N, Gondo K, Takahashi Y, Takeuchi C, Wada R, et al. The association of Helicobacter pylori infection with serum lipid profiles: An evaluation based on a combination of meta-analysis and a propensity score-based observational approach. PloS one. 2020;15(6):e0234433.
Talari HR, Moniri R, Mollaghanbari M, Kashani HH, Jalalian MN. Evaluating the relationship between Helicobacter pylori infection and carotid intima-media thickness a cross sectional study. Annals of Medicine and Surgery. 2021;69:102659.
Ansari S, Yamaoka Y. Helicobacter pylori infection, its laboratory diagnosis, and antimicrobial resistance: a perspective of clinical relevance. Clinical microbiology reviews. 2022;35(3):e00258-21.
George S, Lucero Y, Torres JP, Lagomarcino AJ, O’Ryan M. Gastric damage and cancer-associated biomarkers in Helicobacter pylori-infected children. Frontiers in Microbiology. 2020;11:90.
Lucero Y, Lagomarcino AJ, Torres JP, Roessler P, Mamani N, George S, et al. Helicobacter pylori, clinical, laboratory, and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: A case-control study. International Journal of Infectious Diseases. 2021;103:423-30.
Fang Y, Xie H, Fan C. Association of hypertension with helicobacter pylori: A systematic review and meta‑analysis. PLoS One. 2022;17(5):e0268686.
Xiong X, Chen J, He M, Wu T, Yang H. Helicobacter pylori infection and the prevalence of hypertension in Chinese adults: The Dongfeng‐Tongji cohort. The Journal of Clinical Hypertension. 2020;22(8):1389-95.
Chen MJ, Fang YJ, Wu MS, Chen CC, Chen YN, Yu CC, et al. Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan. Journal of Gastroenterology and Hepatology. 2020;35(2):233-40.
Hussein RA, Al-Ouqaili MT, Majeed YH. Detection of Helicobacter Pylori infection by invasive and non-invasive techniques in patients with gastrointestinal diseases from Iraq: A validation study. Plos one. 2021;16(8):e0256393.
Ito M, Sugiyama A, Mino M, Kodama M, Nagaoki Y, Abe K, et al. Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study. Journal of Gastroenterology. 2022;57(8):540-6.
Кадхим АС, Ал-Карави АС. Insights into the Pathogenesis, Virulence Factors, and Diagnosis of Helicobacter pylori: A Comprehensive Review. in Library. 2023;1(2):31-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 S SHAHID, S ABBASI, S ZULFIQAR, Z ABRAR, W AHMAD, M USMAN
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.